Mount criticism on the unfair behavior of foreign-invested firms

Published: 2002-04-11 06:57:00

Updated: 2002-04-11 06:57:00

Pharmaceutical industry sources say that the unfair behavior of foreign-invested pharmaceutical firms, such as scouting of able salespersons in local pharmaceutical firms and drug wholesalers, and tight money collection period, has raised much criticism from the whole pharmaceutical industry in K...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK